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OBJECTIVE—Pericardial adipose tissue (PAT), a regional fat depot adjacent to the myocar-
dium, may mediate the complex relation between obesity and cardiac left ventricular (LV) ab-
normalities. We sought to evaluate the association of PAT with echocardiographic measures of
LV abnormalities in the Jackson Heart Study (JHS).
RESEARCH DESIGN AND METHODS—Atotalof 1,414AfricanAmericans (35%men;
mean age 58 years) from the JHS underwent computed tomographic assessment of PAT and
abdominal visceral adipose tissue (VAT) from 2007 to 2009 and echocardiography examination
between 2000 and 2004. Echocardiographic measures of left atrial (LA) internal diameter, LV
mass, LV ejection fraction (LVEF), and E-wave velocity-to-A-wave velocity ratio (E/A ratio) were
examined in relation to PAT, VAT, BMI, and waist circumference (WC).
RESULTS—All adiposity measures were positively correlated with LA diameter and LV mass
and negatively correlated with E/A ratio (P = 0.02 to 0.0001) and were not with LVEF (P = 0.36–
0.61). In women, per 1-SD increment of PAT, we observed association with higher LV mass
(9.0 6 1.7 gm, P = 0.0001) and LA diameter (1.0 6 0.1 mm, P = 0.0001). However, the
magnitude of the association between PAT and cardiac measures was similar compared with
VAT(P=0.65[LVmass];P=0.26 [LAdiameter])andwassmallercomparedwithBMI(P=0.002
[LV mass]; P = 0.01 [LA diameter]) and WC (P = 0.009 [LA diameter]).
CONCLUSIONS—PAT is correlated with echocardiographic measures of cardiac LV abnor-
malities, but the association is not stronger than other adiposity measures.
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P
ericardial adipose tissue (PAT) is an
active endocrine organ (1). Because
of the close proximity of PAT to the
underlying myocardium, it has been hy-
pothesized that PAT may have a local del-
eterious effect on cardiac structure and
function (2–4). Several clinical studies
have indicated that PAT is associated
with increased left ventricular (LV) mass
(5), left atrial (LA) enlargement, impaired
LVdiastolicﬁllingfunction(6),andlower
cardiac index (7). However, small sample
sizes, the use of echocardiography to
estimate the thickness of pericardial fat
instead of direct volumetric quantiﬁca-
tion,and thelack ofadjustmentofimpor-
tant covariates limit the interpretation of
these prior studies. Recent data from the
Framingham Heart Study (FHS), a large
population-based cohort, suggested that
pericardial fat volume is correlated with
LV structure and function deﬁned by car-
diac magnetic resonance (8) but not more
so than other measures of adiposity, in-
cluding visceral adipose tissue (VAT).
However, these results from the FHS are
derived predominantly from a European
American population and may not be
generalizable to African American popu-
lationswhereobesityandLVhypertrophy
are highly prevalent (9).
Thus,tobetterunderstandtheimpact
of PAT on cardiac structure and function
in African Americans, we examined the
association of computed tomography
(CT) measures of PAT with echocardio-
graphic measures of LV structure and
function in the Jackson Heart Study
(JHS) cohort.
RESEARCH DESIGN AND
METHODS
Study sample
The JHS recruited 5,301 African Ameri-
cans from the Jackson, MS, metropolitan
area between September 2000 and March
2004. The cohort was composed of four
components: 1) ;31% of the cohort
members were participants from the Ath-
erosclerosis Risk in Communities (ARIC)
study recruited to the JHS; 2) 30% were
representative community volunteers
who met census-derived age, sex, and so-
cioeconomic status eligibility criteria
from the Jackson, MS, metropolitan; 3)
17% were randomly ascertained from
Jackson, MS, through methods described
previously (10); and 4) 22% were in the
JHS family study. The sampling frame for
the family study was participants in any
one of the ARIC, random, or volunteer
samples whose family size met eligibility
requirements as detailed previously (10).
The cohort consisted of5,035adultsaged
35–84 years old and an additional 266
participants (251 participants aged 21–
34 and 15 participants aged .85) who
were added as a part of the JHS family
study. This resulted in a ﬁnal age range
of 21 to 94 years (10). The current study
included participants who underwent
multidetector CT scanning from 2007 to
2009 as a part of the second JHS exami-
nation (JHS Exam 2).
Overall, 4,200 participants attended
the JHS Exam 2. Of these, 1,414 (35%
men)underwentmultidetectorCTassess-
ment for VAT and PAT. Of these 1,414
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ORIGINAL ARTICLEparticipants, 1,402 had a complete covar-
iate proﬁle and the echocardiography
measures. Thus the ﬁnal sample size for
analysis was 1,402. The study protocol
was approved by the institutional review
boardoftheparticipatinginstitutions:the
University of Mississippi Medical Center,
Jackson State University, and Tugaloo
College. All of the participants provided
informed consent.
Multidetector CT scan protocol and
data analysis
The continuous CT-imaging slices of
cardiac/abdominal adipose tissue were
undertaken by multidetector CT (GE
Healthcare Lightspeed 16 Pro, Milwau-
kee, WI) at the Jackson Medical Mall and
were analyzed at the CT reading center at
Wake Forest University. The imaging
slices consist of scout images, one elec-
trocardiogram gated series of the entire
heart that will be used for assessing PAT,
and a series through the lower abdomen
from L3 to S1 that were used for assessing
VAT. The estimated average whole-body
e f f e c t i v ed o s ef o rt h ee n t i r ep r o t o c o lw a s
4 mSv. Scanning procedure for cardiac-
gated CT scans of the coronary arteries is
based on the standard protocols devel-
oped as part of the National Heart, Lung,
and Blood Institute (NHLBI) Multi-
Ethnic Study of Atherosclerosis (MESA)
and Coronary Artery Risk Development
in Young Adults (CARDIA) studies (11).
Nearly44–60continuous2.5-mmmotion-
freeimagingslicescoveringtheentireheart
w e r et a k e nw i t hs t a n d a r dC T - s c a n n i n g
protocol. Participants were excluded
from the CT scan exam if: 1)b o d yw e i g h t
was greater than 350 lbs (;160 kg), 2)
pregnant or pregnancy status was un-
known, and 3) female participant was
,40 years of age or 4) male participant
was ,35 years of age. When compared
with participants who did not undergo
CT scanning, those who did had lower
BMI, waist circumference (WC), and LV
mass; were less frequently diabetic and
current smokers; and had a higher physi-
cal activity score. The Volume Analysis
software tool (GE Healthcare, Waukesha,
WI) was used to discern fat from the re-
mainder of the heart with a threshold of
2190 to 230 Hounsﬁeld units. In this
study, segmentation of PAT was achieved
by isolating the PAT and heart from the
thoraxusingspeciﬁcanatomiclandmarks.
Pericardium was manually traced, and
PAT was deﬁned by any adipose tissue lo-
cated in the pericardial sac (3,8,12). On a
randomselectedsampleof60participants,
intrareader reproducibility was excellent
forPAT(interclasscorrelationcoefﬁcient=
0.96) and for VAT (interclass correlation
coefﬁcient = 0.95).
Echocardiography assessment
Echocardiograms were performed during
the baseline examination (2000–2004).
All cardiac ultrasound examinations
were undertaken with use of a commer-
cially available ultrasound system (Sonos
4500, Hewlett Packard), which includes
software for the acquisition of both stan-
dard ultrasound and Doppler myocardial
imagingdata.Standardechocardiography
analyses included two-dimensional, M-
mode, and Doppler ﬂow measurement
performed according to American Society
of Echocardiography recommendations
(13). All measurements were analyzed
byexperiencedsonographers.LAinternal
diameter was measured at end-systole in
the antero-posterior direction from the
long-axis view. LV mass was calculated
by anatomically validated Devereux’sE q
(14). LV systolic function was described
in terms of the LV ejection fraction
(LVEF), which was calculated as percent
change in LV internal diameters between
systole and diastole (9,15). To estimate
diastolic function, peak early E-wave
and late A-wave velocities were measured
from the transmitral pulsed Doppler
scanning trace and ratio of peak early E-
wave and late A-wave (E/A ratio) veloci-
ties were calculated.
Risk factors and covariate
assessment
Risk factors were obtained from the base-
line examination (2000–2004) (10). BMI
was deﬁned as weight (in kilograms) di-
vided by the square of height (in meters).
WC was measured at the level of the um-
bilicus; two measures of the waist were
averaged to determine waist circumfer-
ence for each participant. Sitting blood
pressure was measured twice at 5-min in-
tervals, and the average of two measure-
ments was used for analysis. Estimated
glomerular ﬁltration rate (eGFR) was cal-
culatedbasedonserumcreatininevaluesus-
ing the isotope dilution mass spectrometry–
traceable 4-variable Modiﬁcation of
Diet in Renal Disease (MDRD). Study
equation (GFR = 186 z [serum creati-
nine]
21.154 z age
20.203 z [0.742 if female] z
[1.21 if African American]) (16). Subjects
were considered to have hypertension if
theyweretakingantihypertensivemedica-
tions, self-reported a diagnosis of hyper-
tension, and/or if their systolic pressure
was $140 mmHg or diastolic pressure
$90 mmHg. Diabetes was deﬁned as a
fasting plasma glucose level $126 mg/dL
ortreatmentwithinsulinorhypoglycemic
agent. Modiﬁed National Cholesterol Ed-
ucation Program Adult Treatment Panel
III criteria were used to deﬁne the meta-
bolic syndrome (17). Alcohol use was
deﬁned as consumption of alcoholic bev-
erageswithinthe past 12months. Current
smoking status was deﬁned as smoking if
the participant smoked at the time of the
interview.
Statistical analysis
We observed a signiﬁcant interaction
between sex and PAT for LVEF (P ,
0.019); therefore, the entire analyses
were stratiﬁed by sex. Age-adjusted Pear-
son correlation coefﬁcients were used to
assess correlations between all adiposity
measures and echocardiography mea-
sures of cardiac structures and functions,
including LV mass, LA diameter, LVEF,
and E/A ratio. All adiposity measures, in-
c l u d i n gP A T ,V A T ,S A T ,B M I ,a n dW C ,
were ﬁrst standardized to a mean of
0 and a standard deviation of 1, and
then the tests for the signiﬁcance of the
differences among BMI, WC, VAT, and
PAT regression coefﬁcients were carried
out within a multivariate standardized re-
gression to estimate the relative impor-
tance of each adiposity in association
with each of the echocardiography mea-
sures. Next, a multivariable regression
model was constructed with either of
PAT,VAT,BMI,orWCastheindependent
variable and echocardiography measures
as dependent variables to assess the sig-
niﬁcance of covariate-adjusted cross-
sectional relations between adiposity
measures and echocardiography mea-
sures. Three models were considered:
1) age, height, smoking, alcohol, systolic
blood pressure, eGFR, hemoglobin, total
physical activity score, and medications
for ACE inhibitors, b-blockers, hyperten-
sion, diabetes, and dyslipidemia; 2) model
1 plus additional adjustment for VAT; and
3) model 1 plus additional adjustment for
body weight. Because of the body weight
adjustment, we did not index echocardio-
graphic measures to body surface area.
Models using BMI or WC as an indepen-
dent variable did not further adjust for
height or VAT due to collinearity. In addi-
tion, we also performed secondary analy-
ses. First, we limited our analysis to
participants with stable BMI from exam 1
to exam 2, which was deﬁned as a differ-
encebetweenBMIfollow-upandBMIbaselineof
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Pericardial fat and cardiac abnormalities,5%. Second, we focused on participants
without cardiovascular disease, including
coronary heart disease, heart failure, or
stroke, in order to assess whether the asso-
ciation was still maintained in the study
during the period from exam 1 to exam
2. SAS version 9.2 was used to perform
allcomputations(SASInstitute,Cary,NC).
RESULTS—Overall, 924 women and
477 men were available for analysis. The
mean age of study sample was 59 years.
Men had higher mean PAT volumes than
women (79.8 6 37.1 cm
3 vs. 67.1 6
29 cm
3, P = 0.0001) as well as mean
VAT volumes (850.4 6 402.5 vs.
789.5 6 363.0, P =0 . 0 0 2 )( T a b l e1 ) .
Correlations between adiposity
measures and echocardiography
measures
Age-adjusted correlations of adiposity
measures with echocardiography mea-
sures are shown in Table 2. In women, all
adiposity measures were positively corre-
lated with LA diameter and LV mass and
negatively correlated with E/A ratio. Sig-
niﬁcant correlations were not observed
with LVEF with the exception of WC.
Similar ﬁndings were also observed in
men, with the exception of LA diameter,
which was not correlated with PAT.
Multivariable-adjusted regression
models
In women, PAT was signiﬁcantly associ-
ated with LV mass after multivariable
adjustment (P , 0.0001; Table 3). The
regression coefﬁcient per 1-SD increase
in PAT for LV mass was 9.0 gm (Model
1, P , 0.0001). However, this regression
coefﬁcient was not different in magnitude
as compared with VAT (9.1 gm, P =0 . 6 5
for b-comparison) or WC (10.3 gm, P =
0.65 for b-comparison) but was smaller
than that of BMI (10.6 gm, P = 0.002 for
difference between PAT and BMI). The
associationofPATwithLVmasspersisted
but was attenuated after additional ad-
justment for VAT (4.5 gm, P =0 . 0 5 )o r
for body weight (4.1 gm, P = 0.03). Sim-
ilar patterns of the association were also
observed in men (Table 3), but the asso-
ciation of PAT with LV mass was not sig-
niﬁcant after additional adjustment for
body weight.
PAT was associated with LA diameter
in women after multivariable adjustment,
but the regression coefﬁcient per 1-SD
increment of PAT (1.04 mm) was smaller
as compared with BMI (1.34 mm, P =
0.001 for difference) or WC (1.34 mm,
P = 0.009 for difference). The association
of PAT with LA diameter remained signif-
icant after additional adjustment for VAT
(0.8mm,P=0.0003)andforbodyweight
(0.4 mm, P = 0.03). Among men, the as-
sociation between PAT and LA diameter
didnotpersistafteradditionaladjustment
for VAT or body weight.
We observed E/A ratio values signiﬁ-
cantly associated with per 1-SD increase in
VAT, BMI, and WC but not in PAT in
women. However, there were no differ-
ences in the regression coefﬁcients among
those of PAT, VAT, BMI, and WC (all P .
0.05).Inaddition,noassociationswereob-
serveduponadditionaladjustmentforVAT
or body weight. In men, no signiﬁcant as-
sociation was found between PAT and E/A
ratio except for BMI (P =0 . 0 4 ) .
In secondary analyses limited to par-
ticipants with stable BMI or in participants
without the presence of cardiovascular
disease, the above associations between
PAT and echocardiographic measures
were maintained (data not shown).
CONCLUSIONS
Principal ﬁndings
In this substudy from the JHS cohort of
1,414 participants undergoing CT and
echocardiography examinations, volu-
metric measures of PAT were correlated
positively with LV mass and LA diameter
and negatively correlated with E/A ratio,
particularly in women. The signiﬁcant
association persisted with LV mass and
LA diameter when additionally adjusting
for VAT or body weight. There was no
association observed between PAT and
LVEF. However, the magnitude of the
association of PAT with measures of LV
Table 1—Clinical characteristics of study participants who underwent assessment of
pericardial fat volumes
Women Men
Age (years) 60 6 11 58 6 11
Pericardial fat (cm
3) 67.1 6 29.0 79.8 6 37.1
Abdominal visceral fat (cm
3)7 9 1 . 3 6 363.3 858.5 6 409.9
BMI (kg/m
2) 32.4 6 7.0 29.4 6 5.1
WC (cm) 99.2 6 16.2 100.2 6 12.9
Height (cm) 164.2 6 6.4 178.1 6 6.6
Left atrial diameter (mm) 35.2 6 4.1 37.1 6 3.9
Left ventricle mass (gm) 135.4 6 40.1 160.8 6 40.2
LV ejection fraction (%) 63.0 6 8.8 60.3 6 9.9
E/A ratio 1.1 6 0.3 1.1 6 0.3
Obesity (%) 58.5 45.9
Diabetes mellitus (%) 15.6 13.5
Metabolic syndrome (%) 41.7 33.2
Hypertension (%) 62.5 59.2
Current smoking (%) 7.9 12.3
Alcohol use (%) 37.2 60.1
Physical activity score 8.3 6 2.5 8.9 6 2.6
Data are means 6 SD unless otherwise indicated.
Table 2—Age-adjusted Pearson correlation coefﬁcients between the adiposity and echo
measures
LV mass P LA diameter P LVEF P E/A ratio P
Women
PAT (cm
3) 0.21 0.0001 0.30 0.0001 20.04 0.36 20.12 0.003
VAT (cm
3) 0.23 0.0001 0.28 0.0001 20.05 0.24 20.10 0.019
BMI (kg/m
2) 0.31 0.0001 0.44 0.0001 20.08 0.058 20.15 0.0002
WC (cm) 0.30 0.0001 0.43 0.0001 20.10 0.021 20.18 0.0001
Men
PAT (cm
3) 0.24 0.0001 0.11 0.065 0.03 0.61 20.12 0.044
VAT (cm
3) 0.22 0.0003 0.11 0.07 0.01 0.84 20.13 0.0278
BMI (kg/m
2) 0.37 0.0001 0.32 0.0001 0.05 0.36 20.15 0.0089
WC (cm) 0.34 0.0001 0.27 0.0001 20.01 0.87 20.15 0.0094
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Liu and Associatesstructure and function was not stronger
than other adiposity measures examined
i n c l u d i n gV A T ,B M I ,a n dW C .T a k e n
together, these results do not support a
special role for PAT in association with
echocardiographic measures of cardiac
structure and function.
In the context of the current
literature
Anatomically, PAT is divided into two
layers:epicardialandparacardialfatlayers.
The epicardial fat layer is mainly lo-
cated around major coronary arteries in
the interventricular and atrioventricular
grooves, with lesser amounts located
around atria and right ventricles; the
paracardial fat layer is situated external
to the parietal layer of the pericardium
within the mediastinum and has alterna-
tively been termed mediastinal fat (12).
Generally, PAT is deﬁned as epicardial
plus paracardial adipose tissue located in
pericardial sac (3,4,8). As a small part of
VAT, direct anatomic contact between
PAT and the myocardium may impact
LV structure and function via mechanical
compression. Such fat depots around the
heartmay mechanicallycompressthecar-
diac atria and ventricles, decreasing LV
compliance and affecting LV diastolic
properties, consequently inducing LV hy-
pertrophy (5,8,18), atrial enlargement,
and impaired LV diastolic ﬁlling (6–8).
In addition, PAT and the underlying
cardiac myocardium share the same cor-
onary blood supply without a separate
fascia between the adipose tissue and
myocardial layers. Thus the cardiac myo-
cardium receives a dual direct supply of
free fatty acid or inﬂammatory cytokines,
including monocyte chemoattractant
protein-1, interleukin (IL)-1b, IL-6, tu-
mor necrosis factor-a, leptin, and others,
from pericardial fat and circulation,
which may alter myocardial energy me-
tabolism (1,7,19–21). Atrial enlarge-
ment, diastolic dysfunction, and LV
hypertrophy are common ﬁndings in
morbidly obese individuals (22).
However, the pathogenic mecha-
nisms of a local or paracrine role for
PAT as compared with the predominant
systemic effects of overall obesity on
cardiac structure and function are not
completelyunderstood.Overallobesityis
associated with higher pressure in the
right side of heart, increased cardiac out-
put, and LV volume and ﬂow (22,23),
which can lead to LV diastolic dysfunc-
tion and impairment of LV systolic func-
tion. Weight loss has been shown to
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Pericardial fat and cardiac abnormalitiesimprove the cardiac performance in mor-
bidly obese patients by improving cardiac
output, LV mass, and systolic and dia-
stolic function (24). These alternations
may be due to hemodynamic changes
predominantly resulting from the in-
creased blood volume and ﬂow required
to adequately perfuse increased body
mass. Given the broadly similar associa-
tions of PAT, VAT, WC, and BMI
with measures of cardiac structure and
function—observed primarily in our
larger female subgroup—our ﬁndings
support the notion that the local effects
of PAT are not stronger than generalized
adiposity in association with cardiac
structure and function abnormality.
Implications
African Americans have been found to
have greater LV mass and higher preva-
lenceofLVhypertrophy(LVH)compared
with European Americans (9,25), and
PAT is hypothesized to be a potential
risk factor for cardiac structure and func-
tion abnormalities because of its close
anatomic contact to the underlying
myocardium (5–7). In the current study,
we demonstrate a signiﬁcant association
of PAT with LV mass and LA diameter.
Nevertheless, we note that PAT is no
more correlated with LV mass and LA di-
ameter than other adiposity measures.
Therefore, our results suggest that the
possible mechanical and paracrine effects
of PAT may not be more pronounced for
measures of cardiac structure and func-
tion than the systemic effects of obesity.
Strengths and limitations
Strengths of this study include a large
sample size from the population-based
JHS cohort, a contemporaneous and
highly reproducible volumetric quantiﬁ-
cation of PAT and VAT, and adjustment
for multiple potential confounders. Lim-
itations include 1) the cross-sectional
study design, which limits our ability to
infer causality; 2) the potential misclassi-
ﬁcation of PAT due to combined mea-
surement of pericardial and epicardial
fat inherent in our methodology; 3)l a c k
of tissue Doppler measures of diastolic
function and low availability of decelera-
tion time and isovolumic relaxation time
intheechocardiographymeasures;and4)
the potential misclassiﬁcation of risk fac-
tors that exists due to the time gap be-
tween the clinical echocardiography
measures and CT measures of PAT and
VAT.However,theresultsfromthesecond-
ary analyses indicate that the associations
between PAT and cardiac structure and
function are still maintained in this study
during the time period from exam 1 to
exam 2. Thus we do not expect that this
time gap should impact the relative asso-
ciation of PAT compared with other adi-
posity measures with cardiac structure
and function in this study.
PATisassociatedwithhigherlevelsof
LV mass and LA diameter, but the as-
sociation is not stronger than other adi-
posity measures, including VAT, BMI,
and WC.
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